找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊CNS DRUGS 2024/2025影响因子:7.485 (CNS DRUGS) (1172-7047). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Ex  ...234
Total Citations:6454; 2023 JIF:7.485; JIFRank: 14/354 ; Rank-JIF: 14; Number-of-JIF:354; 5 Year JIF:6.413; 5 Year JIF Quartile:Q1; JIF Without Self Cites:7.2; Immediacy Index:1; Immediacy Index-dealt:1.178; 2023 JCI:1.46; JCI Rank: 27/354 ; Total Articles:37; JCI Quartile:Q1; JCI Percentile:92.51; Eigenfactor:0.006; Normalized Eigenfactor:1.379; Article Influence Score:1.821; JIF Percentile:96.2; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:67; % of Articles in Citable items:0.5522; Cited Half-Life:7; Citing Half-Life:6.8; % of OA Gold:0.5378; Publisher name:JAPANESE SOC BREEDING; Publisher address:UNIV TOKYO, GRADUATE SCHOOL AGRICULTURAL
投票 SCIE期刊FUNDAMENTAL & CLINICAL PHARMACOLOGY 2024/2025影响因子:2.172 (FUND CLIN PHARMACOL) (0767-3981). (PHARMACOLOGY & PHARMA  ...234
Total Citations:2834; 2023 JIF:2.172; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.314; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.8; Immediacy Index:0.6; Immediacy Index-dealt:0.688; 2023 JCI:0.67; JCI Rank: 171/354 ; Total Articles:69; JCI Quartile:Q2; JCI Percentile:51.84; Eigenfactor:0.002; Normalized Eigenfactor:0.36; Article Influence Score:0.447; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:97; % of Articles in Citable items:0.7113; Cited Half-Life:8.8; Citing Half-Life:7.5; % of OA Gold:0.0775; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:0.929 (INT J CLIN PHARM TH) (0946-1  ...234
Total Citations:1690; 2023 JIF:0.929; JIFRank: 309/354 ; Rank-JIF: 309; Number-of-JIF:354; 5 Year JIF:0.929; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.2; Immediacy Index-dealt:0.218; 2023 JCI:0.28; JCI Rank: 298/354 ; Total Articles:76; JCI Quartile:Q4; JCI Percentile:15.96; Eigenfactor:0.001; Normalized Eigenfactor:0.151; Article Influence Score:0.203; JIF Percentile:12.9; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:81; % of Articles in Citable items:0.9383; Cited Half-Life:11.9; Citing Half-Life:7.9; % of OA Gold:0; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United S
投票 SCIE期刊DRUG RESISTANCE UPDATES 2024/2025影响因子:15.833 (DRUG RESIST UPDATE) (1368-7646). (PHARMACOLOGY & PHARMACY)(药理学与药学)S  ...234
Total Citations:4913; 2023 JIF:15.833; JIFRank: 3/354 ; Rank-JIF: 3; Number-of-JIF:354; 5 Year JIF:18.175; 5 Year JIF Quartile:Q1; JIF Without Self Cites:15.1; Immediacy Index:3.3; Immediacy Index-dealt:3.316; 2023 JCI:2.6; JCI Rank: 5/354 ; Total Articles:39; JCI Quartile:Q1; JCI Percentile:98.73; Eigenfactor:0.004; Normalized Eigenfactor:0.808; Article Influence Score:3.747; JIF Percentile:99.3; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:72; % of Articles in Citable items:0.5417; Cited Half-Life:6.3; Citing Half-Life:5.4; % of OA Gold:0.4; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND, OX2 6DP;
投票 SCIE期刊BIOCHEMICAL PHARMACOLOGY 2024/2025影响因子:5.328 (BIOCHEM PHARMACOL) (0006-2952). (PHARMACOLOGY & PHARMACY)(药理学与药学)Sc  ...234
Total Citations:30835; 2023 JIF:5.328; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:5.223; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5.2; Immediacy Index:0.9; Immediacy Index-dealt:0.991; 2023 JCI:1.41; JCI Rank: 32/354 ; Total Articles:286; JCI Quartile:Q1; JCI Percentile:91.1; Eigenfactor:0.019; Normalized Eigenfactor:4.043; Article Influence Score:1.109; JIF Percentile:90.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:457; % of Articles in Citable items:0.6258; Cited Half-Life:10.3; Citing Half-Life:7; % of OA Gold:0.2083; Publisher name:JOHNS HOPKINS UNIV PRESS; Publisher address:JOURNALS PUBLISHING DIVISION, 271
投票 SCIE期刊PHARMAZIE 2024/2025影响因子:1.599 (PHARMAZIE) (0031-7144). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation Index Ex  ...234
Total Citations:3399; 2023 JIF:1.599; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:1.478; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.5; Immediacy Index:0.2; Immediacy Index-dealt:0.212; 2023 JCI:0.29; JCI Rank: 293/354 ; Total Articles:39; JCI Quartile:Q3; JCI Percentile:35.28; Eigenfactor:0.001; Normalized Eigenfactor:0.283; Article Influence Score:0.27; JIF Percentile:33.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:41; % of Articles in Citable items:0.9512; Cited Half-Life:12.5; Citing Half-Life:9.5; % of OA Gold:0; Publisher name:SCIENCE PRESS; Publisher address:16 DONGHUANGCHENGGEN NORTH ST, BEIJING, PEOPLES
投票 SCIE期刊Cardiovascular Therapeutics 2024/2025影响因子:3.404 (CARDIOVASC THER) (1755-5914). (PHARMACOLOGY & PHARMACY)(药理学与药学)S  ...234
Total Citations:1745; 2023 JIF:3.404; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.225; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:0.6; Immediacy Index-dealt:0.681; 2023 JCI:0.8; JCI Rank: 125/354 ; Total Articles:29; JCI Quartile:Q2; JCI Percentile:64.83; Eigenfactor:0.002; Normalized Eigenfactor:0.333; Article Influence Score:0.73; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:34; % of Articles in Citable items:0.8529; Cited Half-Life:6.3; Citing Half-Life:7.4; % of OA Gold:0.9928; Publisher name:PERGAMON-ELSEVIER SCIENCE LTD; Publisher address:THE BOULEVARD, LANGFORD LANE
投票 SCIE期刊CLINICAL DRUG INVESTIGATION 2024/2025影响因子:2.922 (CLIN DRUG INVEST) (1173-2563). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:2713; 2023 JIF:2.922; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:2.558; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.8; Immediacy Index:0.6; Immediacy Index-dealt:0.666; 2023 JCI:0.8; JCI Rank: 125/354 ; Total Articles:65; JCI Quartile:Q2; JCI Percentile:64.83; Eigenfactor:0.003; Normalized Eigenfactor:0.631; Article Influence Score:0.655; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:85; % of Articles in Citable items:0.7647; Cited Half-Life:5.9; Citing Half-Life:5.5; % of OA Gold:0.4496; Publisher name:GRUPO ESPANOL CARBON; Publisher address:INST CARBOQUIMICA, MIGUEL LESMA CAST
投票 SCIE期刊Journal of Biopharmaceutical Statistics 2024/2025影响因子:1.239 (J BIOPHARM STAT) (1054-3406). (PHARMACOLOGY & PHARMA  ...234
Total Citations:1555; 2023 JIF:1.239; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.365; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.5; Immediacy Index-dealt:0.526; 2023 JCI:0.51; JCI Rank: 232/354 ; Total Articles:90; JCI Quartile:Q3; JCI Percentile:47.92; Eigenfactor:0.002; Normalized Eigenfactor:0.435; Article Influence Score:0.693; JIF Percentile:56.3; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:90; % of Articles in Citable items:1; Cited Half-Life:10.3; Citing Half-Life:9.8; % of OA Gold:0.0977; Publisher name:BMC; Publisher address:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW;
投票 SCIE期刊European Heart Journal-Cardiovascular Pharmacotherapy 2024/2025影响因子:5.387 (EUR HEART J-CARD PHA) (2055-6837). (PH  ...234
Total Citations:1629; 2023 JIF:5.387; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:5.101; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.5; Immediacy Index:1.4; Immediacy Index-dealt:1.442; 2023 JCI:1.67; JCI Rank: 20/354 ; Total Articles:46; JCI Quartile:Q1; JCI Percentile:94.49; Eigenfactor:0.003; Normalized Eigenfactor:0.738; Article Influence Score:1.598; JIF Percentile:90.5; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:63; % of Articles in Citable items:0.7302; Cited Half-Life:2.7; Citing Half-Life:4.7; % of OA Gold:0.2236; Publisher name:BRILL; Publisher address:PLANTIJNSTRAAT 2, P O BOX 9000, LEIDEN, NETHERLANDS,
投票 SCIE期刊CURRENT DRUG TARGETS 2024/2025影响因子:3.177 (CURR DRUG TARGETS) (1389-4501). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc  ...234
Total Citations:6093; 2023 JIF:3.177; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.318; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.5; Immediacy Index-dealt:0.517; 2023 JCI:0.43; JCI Rank: 262/354 ; Total Articles:13; JCI Quartile:Q3; JCI Percentile:26.13; Eigenfactor:0.003; Normalized Eigenfactor:0.712; Article Influence Score:0.587; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:94; % of Articles in Citable items:0.1383; Cited Half-Life:7.8; Citing Half-Life:8.5; % of OA Gold:0.0061; Publisher name:CELL PRESS; Publisher address:50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 0
投票 SCIE期刊Pakistan Journal of Pharmaceutical Sciences 2024/2025影响因子:0.754 (PAK J PHARM SCI) (1011-601X). (PHARMACOLOGY & PH  ...234
Total Citations:3110; 2023 JIF:0.754; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.833; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.138; 2023 JCI:0.21; JCI Rank: 315/354 ; Total Articles:226; JCI Quartile:Q4; JCI Percentile:11.16; Eigenfactor:0.002; Normalized Eigenfactor:0.353; Article Influence Score:0.114; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:226; % of Articles in Citable items:1; Cited Half-Life:6.4; Citing Half-Life:5.7; % of OA Gold:0; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
投票 SCIE期刊MOLECULAR PHARMACOLOGY 2024/2025影响因子:3.284 (MOL PHARMACOL) (0026-895X). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science  ...234
Total Citations:13017; 2023 JIF:3.284; JIFRank: 124/354 ; Rank-JIF: 124; Number-of-JIF:354; 5 Year JIF:3.541; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.1; Immediacy Index:0.7; Immediacy Index-dealt:0.728; 2023 JCI:0.87; JCI Rank: 109/354 ; Total Articles:49; JCI Quartile:Q2; JCI Percentile:69.35; Eigenfactor:0.004; Normalized Eigenfactor:0.906; Article Influence Score:0.997; JIF Percentile:65.1; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:52; % of Articles in Citable items:0.9423; Cited Half-Life:15.9; Citing Half-Life:9.3; % of OA Gold:0.2459; Publisher name:AUSTRALIAN POLITICAL ECONOMY MOVEMENT; Publisher address:UNIV SYDNEY, BOX
投票 SCIE期刊Advanced Therapeutics 2024/2025影响因子:3.752 (ADV THER-GERMANY) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Cit  ...234
Total Citations:2818; 2023 JIF:3.752; JIFRank: 90/354 ; Rank-JIF: 90; Number-of-JIF:354; 5 Year JIF:4.751; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.6; Immediacy Index:0.7; Immediacy Index-dealt:0.797; 2023 JCI:0.98; JCI Rank: 84/354 ; Total Articles:110; JCI Quartile:Q1; JCI Percentile:76.41; Eigenfactor:0.004; Normalized Eigenfactor:0.952; Article Influence Score:0.918; JIF Percentile:74.7; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:162; % of Articles in Citable items:0.679; Cited Half-Life:3.5; Citing Half-Life:5.6; % of OA Gold:0.2595; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United
投票 SCIE期刊PHARMACOTHERAPY 2024/2025影响因子:2.917 (PHARMACOTHERAPY) (0277-0008). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citat  ...234
Total Citations:6647; 2023 JIF:2.917; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:3.859; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:1; Immediacy Index-dealt:1.181; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:74; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.005; Normalized Eigenfactor:1.039; Article Influence Score:1.164; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:119; % of Articles in Citable items:0.6218; Cited Half-Life:9.6; Citing Half-Life:6.9; % of OA Gold:0.1749; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE,
投票 SCIE期刊BIOLOGICAL & PHARMACEUTICAL BULLETIN 2024/2025影响因子:1.746 (BIOL PHARM BULL) (0918-6158). (PHARMACOLOGY & PHARMACY)  ...234
Total Citations:11486; 2023 JIF:1.746; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.946; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:0.3; Immediacy Index-dealt:0.349; 2023 JCI:0.54; JCI Rank: 223/354 ; Total Articles:234; JCI Quartile:Q3; JCI Percentile:37.15; Eigenfactor:0.004; Normalized Eigenfactor:0.876; Article Influence Score:0.358; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:243; % of Articles in Citable items:0.963; Cited Half-Life:12.4; Citing Half-Life:9.3; % of OA Gold:0.9868; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, U
投票 SCIE期刊European Journal of Pharmacology 2024/2025影响因子:4.263 (EUR J PHARMACOL) (0014-2999). (PHARMACOLOGY & PHARMACY)(药理学  ...234
Total Citations:37158; 2023 JIF:4.263; JIFRank: 75/354 ; Rank-JIF: 75; Number-of-JIF:354; 5 Year JIF:4.313; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.1; Immediacy Index:0.8; Immediacy Index-dealt:0.825; 2023 JCI:1.32; JCI Rank: 40/354 ; Total Articles:584; JCI Quartile:Q1; JCI Percentile:88.84; Eigenfactor:0.022; Normalized Eigenfactor:4.72; Article Influence Score:0.794; JIF Percentile:79; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:597; % of Articles in Citable items:0.9782; Cited Half-Life:8.6; Citing Half-Life:6.5; % of OA Gold:0.143; Publisher name:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD; Publisher address:24-28 OVAL RD, LOND
投票 SCIE期刊PEDIATRIC DRUGS 2024/2025影响因子:3.424 (PEDIATR DRUGS) (1174-5878). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citatio  ...234
Total Citations:1897; 2023 JIF:3.424; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.489; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.5; Immediacy Index-dealt:0.545; 2023 JCI:1.03; JCI Rank: 78/354 ; Total Articles:23; JCI Quartile:Q1; JCI Percentile:78.11; Eigenfactor:0.002; Normalized Eigenfactor:0.463; Article Influence Score:0.98; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:52; % of Articles in Citable items:0.4423; Cited Half-Life:6.2; Citing Half-Life:6.5; % of OA Gold:0.2927; Publisher name:ELSEVIER SCIENCE SA; Publisher address:PO BOX 564, LAUSANNE, SWITZERLAND, 100
投票 SCIE期刊Journal of Applied Biomedicine 2024/2025影响因子:2.180 (J APPL BIOMED) (1214-021X). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:720; 2023 JIF:2.180; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:1.708; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.9; Immediacy Index:0.4; Immediacy Index-dealt:0.477; 2023 JCI:0.44; JCI Rank: 257/354 ; Total Articles:24; JCI Quartile:Q3; JCI Percentile:27.54; Eigenfactor:0; Normalized Eigenfactor:0.07; Article Influence Score:0.274; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:25; % of Articles in Citable items:0.96; Cited Half-Life:7.8; Citing Half-Life:8.4; % of OA Gold:1; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK
投票 SCIE期刊Clinical Psychopharmacology and Neuroscience 2024/2025影响因子:2.406 (CLIN PSYCHOPHARM NEU) (1738-1088). (PHARMACOLOG  ...234
Total Citations:1551; 2023 JIF:2.406; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.857; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2; Immediacy Index:0.6; Immediacy Index-dealt:0.637; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:61; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.002; Normalized Eigenfactor:0.405; Article Influence Score:0.659; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:80; % of Articles in Citable items:0.7625; Cited Half-Life:4.7; Citing Half-Life:9.2; % of OA Gold:1; Publisher name:INST TECNOLOGIA PARANA; Publisher address:RUA PROF ALGACYR MUNHOZ MADER 3775-CIC, CU
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 10:43
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块